Lundbeck Investor

Lundbeck is a pharmaceutical company that develops products to treat people with psychiatric and neurological disorders.
Technology: Health Care, Health Diagnostics, Medical
Industry: End-to-end Drug Development
Headquarters: Valby, Hovedstaden, Denmark
Founded Date: 2000-01-01
Employees Number: 5001-10000
Funding Status: IPO
Investor Type: Undisclosed
Investment Stage: Undisclosed
Number Of Exits: 1
Acquisitions Number: 1
Investors Number: 1
Estimated Revenue: $500M to $1B
Last Funding Date: 2020-03-04
Last Funding Type: Grant

Visit Website
Register and Claim Ownership